Loading filing…
Capital Markets Day Ont Expands Into Clinical
Raw text of the filing as fed to Claude Opus 4.7 during the analysis of OXFORD NANOPORE TECHNOLOGIES PLC. Citations in the research note reference this document.
Raw text of the filing as fed to Claude Opus 4.7 during the analysis of OXFORD NANOPORE TECHNOLOGIES PLC. Citations in the research note reference this document.
Loading filing…